Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07173530 · ClinicalTrials.gov registry record · NA
Low Level Light Therapy & Skin Pigmentation
A NA study of Dry Eye and Meibomian Gland Dysfunction (Disorder), sponsored by University of Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07173530: Recruiting NA study of Dry Eye and Meibomian Gland Dysfunction (Disorder), sponsored by University of Houston.
NCT07173530 is a NA study of Dry Eye and Meibomian Gland Dysfunction (Disorder) that is actively recruiting participants, run by University of Houston. The registered enrollment target is 40 participants, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07173530, a NA study of Dry Eye and Meibomian Gland Dysfunction (Disorder), is actively recruiting participants, sponsored by University of Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to determine if there is a difference in eyelid temperature after low-level light therapy (LLLT) in individuals with different amounts of skin pigmentation and dry eye/meibomian gland disease. Participants will have 3 fifteen minute in office LLLT therapy sessions over a period of approximately 7 to 14 days.
Conditions Studied
Interventions
- DEVICE Three 15-minute low-level light therapy sessions using Light Emitting Diodes of wavelength 633nm (Essilor epi-c plus).
Study Locations (1)
Texas
- The University of Houston College of Optometry - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT07173530 shows while recruiting
NCT07173530 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (58% lower).
The record links to 2 conditions, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which Three 15-minute low-level light therapy sessions using Light Emitting Diodes of wavelength 633nm (Essilor epi-c plus). is the first listed.
NCT07173530 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07173530 about?
NCT07173530 is a clinical study titled "Low Level Light Therapy & Skin Pigmentation". The goal of this clinical trial is to determine if there is a difference in eyelid temperature after low-level light therapy (LLLT) in individuals with different amounts of skin pigmentation and dry eye/meibomian gland disease. Participants will have 3 fifteen minute in office LLLT therapy sessions ...
What is the current status of trial NCT07173530?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-06-11. Estimated completion is 2026-08.
What conditions does trial NCT07173530 study?
This clinical trial studies the following conditions: Dry Eye, Meibomian Gland Dysfunction (Disorder).
What interventions are being tested in trial NCT07173530?
The interventions under investigation include: Three 15-minute low-level light therapy sessions using Light Emitting Diodes of wavelength 633nm (Essilor epi-c plus). (DEVICE).
Who is sponsoring clinical trial NCT07173530?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07173530 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07173530's enrollment target sits among peer trials
40 24th of 41 higher than 16 of 41 other Dry Eye trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The THINK Study Incidence of Neurotrophic Keratopathy)
RECRUITING · NA
-
Corneal Epithelial Stem Cells and Dry Eye Disease
COMPLETED · NA
-
Acute Comfort of Lubricant Eye Drops FID 112903
COMPLETED · NA
-
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
COMPLETED · NA
-
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea
COMPLETED · NA
-
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI